CLOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Nexgel

NEXGEL Advanced Hydrogel Solutions in a manufacturer of unique trans-dermal delivery system that was originally developed and FDA-approved for the Hospital Wound Care market, and is now being deployed against Consumer OTC, Rx, Medical Device and Cosmetic applications.

Cuattro

Cuattro LLC is a Pekin, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Seagate Alliance

Seagate Alliance is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Line Medical Inc

New Line Medical Inc is a Breaux Bridge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Columbia St. Mary's Hospital

Over the years we have always placed the needs of those we serve as our highest priority. We have earned a reputation for providing excellent state-of-the art medical care in a family-centered, healing environment.